NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.35% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.21% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.95% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.93% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.85% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.83% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.60% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.57% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.56% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.39% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 3.91% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.78% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.36% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.12% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| VCEL | Vericel Corp Ord | Healthcare | Biotechnology | 3.02% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.98% |